BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7852317)

  • 1. Cell-mediated catabolism of aggrecan. Evidence that cleavage at the "aggrecanase" site (Glu373-Ala374) is a primary event in proteolysis of the interglobular domain.
    Lark MW; Gordy JT; Weidner JR; Ayala J; Kimura JH; Williams HR; Mumford RA; Flannery CR; Carlson SS; Iwata M
    J Biol Chem; 1995 Feb; 270(6):2550-6. PubMed ID: 7852317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interglobular domain of cartilage aggrecan is cleaved by hemorrhagic metalloproteinase HT-d (atrolysin C) at the matrix metalloproteinase and aggrecanase sites.
    Tortorella MD; Pratta MA; Fox JW; Arner EC
    J Biol Chem; 1998 Mar; 273(10):5846-50. PubMed ID: 9488721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane type 1 matrix metalloproteinase (MT1-MMP) cleaves the recombinant aggrecan substrate rAgg1mut at the 'aggrecanase' and the MMP sites. Characterization of MT1-MMP catabolic activities on the interglobular domain of aggrecan.
    Büttner FH; Hughes CE; Margerie D; Lichte A; Tschesche H; Caterson B; Bartnik E
    Biochem J; 1998 Jul; 333 ( Pt 1)(Pt 1):159-65. PubMed ID: 9639575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies that specifically recognize neoepitope sequences generated by 'aggrecanase' and matrix metalloproteinase cleavage of aggrecan: application to catabolism in situ and in vitro.
    Hughes CE; Caterson B; Fosang AJ; Roughley PJ; Mort JS
    Biochem J; 1995 Feb; 305 ( Pt 3)(Pt 3):799-804. PubMed ID: 7531436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The intermediates of aggrecanase-dependent cleavage of aggrecan in rat chondrosarcoma cells treated with interleukin-1.
    Sandy JD; Thompson V; Doege K; Verscharen C
    Biochem J; 2000 Oct; 351(Pt 1):161-6. PubMed ID: 10998358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The structure of aggrecan fragments in human synovial fluid. Evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the Glu 373-Ala 374 bond of the interglobular domain.
    Sandy JD; Flannery CR; Neame PJ; Lohmander LS
    J Clin Invest; 1992 May; 89(5):1512-6. PubMed ID: 1569188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of aggrecan retained and lost from the extracellular matrix of articular cartilage. Involvement of carboxyl-terminal processing in the catabolism of aggrecan.
    Ilic MZ; Robinson HC; Handley CJ
    J Biol Chem; 1998 Jul; 273(28):17451-8. PubMed ID: 9651333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADAMTS4 cleaves at the aggrecanase site (Glu373-Ala374) and secondarily at the matrix metalloproteinase site (Asn341-Phe342) in the aggrecan interglobular domain.
    Westling J; Fosang AJ; Last K; Thompson VP; Tomkinson KN; Hebert T; McDonagh T; Collins-Racie LA; LaVallie ER; Morris EA; Sandy JD
    J Biol Chem; 2002 May; 277(18):16059-66. PubMed ID: 11854269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
    Little CB; Flannery CR; Hughes CE; Mort JS; Roughley PJ; Dent C; Caterson B
    Biochem J; 1999 Nov; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chondrocyte-mediated catabolism of aggrecan: aggrecanase-dependent cleavage induced by interleukin-1 or retinoic acid can be inhibited by glucosamine.
    Sandy JD; Gamett D; Thompson V; Verscharen C
    Biochem J; 1998 Oct; 335 ( Pt 1)(Pt 1):59-66. PubMed ID: 9742213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sites of aggrecan cleavage by recombinant human aggrecanase-1 (ADAMTS-4).
    Tortorella MD; Pratta M; Liu RQ; Austin J; Ross OH; Abbaszade I; Burn T; Arner E
    J Biol Chem; 2000 Jun; 275(24):18566-73. PubMed ID: 10751421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine-induced cartilage proteoglycan degradation is mediated by aggrecanase.
    Arner EC; Hughes CE; Decicco CP; Caterson B; Tortorella MD
    Osteoarthritis Cartilage; 1998 May; 6(3):214-28. PubMed ID: 9682788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human aggrecan G1-G2 exhibits native binding properties and substrate specificity for matrix metalloproteinases and aggrecanase.
    Mercuri FA; Doege KJ; Arner EC; Pratta MA; Last K; Fosang AJ
    J Biol Chem; 1999 Nov; 274(45):32387-95. PubMed ID: 10542281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunolocalization of the cleavage of the aggrecan core protein at the Asn341-Phe342 bond, as an indicator of the location of the metalloproteinases active in the lysis of the rat growth plate.
    Lee ER; Lamplugh L; Leblond CP; Mordier S; Magny MC; Mort JS
    Anat Rec; 1998 Sep; 252(1):117-32. PubMed ID: 9737748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases, and cathepsin B.
    Fosang AJ; Neame PJ; Last K; Hardingham TE; Murphy G; Hamilton JA
    J Biol Chem; 1992 Sep; 267(27):19470-4. PubMed ID: 1326552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cleavage of native cartilage aggrecan by neutrophil collagenase (MMP-8) is distinct from endogenous cleavage by aggrecanase.
    Arner EC; Decicco CP; Cherney R; Tortorella MD
    J Biol Chem; 1997 Apr; 272(14):9294-9. PubMed ID: 9083065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related changes in aggrecan glycosylation affect cleavage by aggrecanase.
    Pratta MA; Tortorella MD; Arner EC
    J Biol Chem; 2000 Dec; 275(50):39096-102. PubMed ID: 10991945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in the interglobular domain of aggrecan alter matrix metalloproteinase and aggrecanase cleavage patterns. Evidence that matrix metalloproteinase cleavage interferes with aggrecanase activity.
    Mercuri FA; Maciewicz RA; Tart J; Last K; Fosang AJ
    J Biol Chem; 2000 Oct; 275(42):33038-45. PubMed ID: 11032846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Truncation of the amino-terminus of the recombinant aggrecan rAgg1mut leads to reduced cleavage at the aggrecanase site. Efficient aggrecanase catabolism may depend on multiple substrate interactions.
    Hörber C; Büttner FH; Kern C; Schmiedeknecht G; Bartnik E
    Matrix Biol; 2000 Nov; 19(6):533-43. PubMed ID: 11068207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a stromelysin cleavage site within the interglobular domain of human aggrecan. Evidence for proteolysis at this site in vivo in human articular cartilage.
    Flannery CR; Lark MW; Sandy JD
    J Biol Chem; 1992 Jan; 267(2):1008-14. PubMed ID: 1730630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.